Protagonist Therapeutics
PTGX
PTGX
64 hedge funds and large institutions have $189M invested in Protagonist Therapeutics in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 66 → 64 (-2)
Holders
64
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.8M | |
| 2 | +$5.08M | |
| 3 | +$4.85M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$4.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.14M |
Top Sellers
| 1 | -$6.49M | |
| 2 | -$6.43M | |
| 3 | -$5.15M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$1.05M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$762K |